Skip to content
Screener

Gross Profit at other companies

Abbott logo
AbbottABT
$7.27B+15.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.26B+7.1%
Boston Scientific logo
Boston ScientificBSX
$3.85B+12.4%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$184.8M+7.4%
AngioDynamics logo
AngioDynamicsANGO
$46.77M+10.8%

Other financials

Income statement

See full
Revenue$434.0K
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%
P/S2,233.4×

Profitability

See full
Gross margin-0.1%
Operating margin-7,007.8%
Net margin-6,755.8%
FCF margin-5,180.4%

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s gross profit?
Pulse Biosciences, Inc. (PLSE) reported gross profit of $161K in Q2 2026.
What is the long-term trend for Pulse Biosciences, Inc.'s gross profit?
Over 2 years (2022 to 2025), Pulse Biosciences, Inc.'s gross profit has grown at a -86.9% compound annual growth rate (CAGR), from -$11.24M to -$193K.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Pulse Biosciences, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude